Sélection de la langue

Search

Sommaire du brevet 1092117 

Énoncé de désistement de responsabilité concernant l'information provenant de tiers

Une partie des informations de ce site Web a été fournie par des sources externes. Le gouvernement du Canada n'assume aucune responsabilité concernant la précision, l'actualité ou la fiabilité des informations fournies par les sources externes. Les utilisateurs qui désirent employer cette information devraient consulter directement la source des informations. Le contenu fourni par les sources externes n'est pas assujetti aux exigences sur les langues officielles, la protection des renseignements personnels et l'accessibilité.

Disponibilité de l'Abrégé et des Revendications

L'apparition de différences dans le texte et l'image des Revendications et de l'Abrégé dépend du moment auquel le document est publié. Les textes des Revendications et de l'Abrégé sont affichés :

  • lorsque la demande peut être examinée par le public;
  • lorsque le brevet est émis (délivrance).
(12) Brevet: (11) CA 1092117
(21) Numéro de la demande: 293065
(54) Titre français: METHODE DE PRODUCTION DE LA 6,7-DIMETHOXY-4-AMINO-2- ¬4-(2-FUROYL)-1-PIPERAZINYL| QUINAZOLINE AYANT UN EFFET ANTIHYPERTENSEUR
(54) Titre anglais: METHOD FOR THE PRODUCTION OF 6,7-DIMETHOXY-4-AMINO-2- ¬4-(2-FUROYL)-1-PIPERAZINYL| QUINAZOLINE HAVING AN ANTIHYPERTENSIVE EFFECT
Statut: Périmé
Données bibliographiques
(52) Classification canadienne des brevets (CCB):
  • 260/253
(51) Classification internationale des brevets (CIB):
  • C07D 405/14 (2006.01)
  • C07C 331/28 (2006.01)
  • C07D 307/68 (2006.01)
(72) Inventeurs :
  • HONKANEN, ERKKI J. (Finlande)
  • PIPPURI, AINO K. (Finlande)
(73) Titulaires :
  • ORION-YHTYMA OY (Finlande)
(71) Demandeurs :
(74) Agent: MARCUS & ASSOCIATES
(74) Co-agent:
(45) Délivré: 1980-12-23
(22) Date de dépôt: 1977-12-14
Licence disponible: Oui
(25) Langue des documents déposés: Anglais

Traité de coopération en matière de brevets (PCT): Non

(30) Données de priorité de la demande:
Numéro de la demande Pays / territoire Date
76 3613 Finlande 1976-12-15

Abrégés

Abrégé anglais



ABSTRACT OF THE DISCLOSURE
A novel process is provided for the preparation of 6,7-dimethoxy-4-
amino-2[4-(2-furoyl)-1-piperazinyl]quinazoline. It includes as a final step,
cyclizing methyl-N-(3,4-dimethoxy-6-cyanophenyl)-[4-(2-furoyl)-1-piperazinyl]
thioformamidate by heating, together with ammonia, in a polar solvent, in the
presence of an alkali metal amide. The methyl-N-(3,4-dimethoxy-6-cyanophenyl)-
[4-(2-furoyl)-1-piperazinyl]thioformamidate is preferably formed by reacting
3,4-dimethoxy-6-[4-(2-furoyl)-1-piperazinyl-thiocarbamido]benzonitrile with methyl
chloride. By this process the quinazoline ring in prazosine is produced within
the molecule, rather than in a reaction between two different molecules.

Revendications

Note : Les revendications sont présentées dans la langue officielle dans laquelle elles ont été soumises.



THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. In a process for preparing 6,7-dimethoxy-4-amino-2-[4-(2-
furoyl)-1-piperazinyl]quinazoline having the formula:

Image
I
the improvement which comprises cyclizing methyl N-(3,4-dimethoxy-6-cyano-
phenyl)-[4-(2-furoyl)-1-piperazinyl]thioformamidate having the formula:

Image
III
by heating, together with ammonia, in a polar solvent in the presence of an
alkali metal amide.
2. The improvement of claim 1 wherein said compound having formu-
la (III) is prepared by reacting 3,4-dimethoxy-6-[4-(2-furoyl)-1-piperazinyl-
thiocarbamido]benzonitrile having the formula:

Image

II
with methyl iodide.
3. The improvement of claim 2 wherein said reaction of the com-
pound having Formula (II) with methyl iodide is performed in formamide,
in N,N-dimethyl formamide, in bis-methoxyethyl ether (diglyme), or in a mix-
ture of said solvents, at 50°-100°C.


4. The improvement of Claims 1, 2 or 3, wherein said cyclization
is performed in formamide or in N,N-dimethyl formamide at 100°-150°C, using
1-3 equivalents of an alkali amide.
5. The improvement of Claims 1, 2 or 3, wherein said reaction of
the compound having Formula II with methyl iodide and said cyclization of the
compound having Formula III is performed continuously in one and the same
solvent without separating the intermediate products.


Description

Note : Les descriptions sont présentées dans la langue officielle dans laquelle elles ont été soumises.


09~l7
The present invention relates to a novel process for producing
6,7-dimethoxy-4-a~lno-2-~4-(2-furoyl)-1-piperazinyl] quinazoline, a con~iound
having an antihypertensive effect.
This co~ound, which is known as prazosine, is known to have a
strong antih~pertensive effect (Cohen, Journal of Clinieal Pharmacology,

0 (1970) ) ~ e formula of the comp~und is

3 ~ ~rN N - C


N H2
I
Several proeesses have been disclosed in U.S. Patent 3 511 836 for
producing 6,7~dimethoxy-4~amino-2-~4-substituted)-1-piperazinyl] ~uinazo-
lines. One of these processes for pr~ducing pra~osine is to cause 6,7-di-
methoxy-4-amino-2-ehloro_quinazoline to react with (2-fry~yl)-1-piperazine
aeeording to the reaction fornLla below:




)~ + H-N~ - OC ~ ~ pr~ osine
:~ 20 2

:~ .
Duteh Patent 7206067 discloses another process for producing,
among other things, prazosine, and aecording to this proeess 3,4-dimetho~y-
6-aminobenzonitrile is caused to reaet with l-eyano-4-~2 furoyl)-piperazine
according to ~he reaction fornNla below:


G 3 ~ H2 ~ O
3 ~ NC - N N - OC ~ ~ prazos ne


-2-

117

One prior art process for producing prazosine is illustrated
by the reactin ~ormula below:


C 30 ~ ~ ~ ~ ~rdZoS~e




NH NH NH NH

where Q = CN or C and A = CN, C ~ ~ C\ or C
2 NH2 OR SR


in which case R = an alkyl with 1-6 carbon atoms; however,
when Q is CN, A is c~NH or C~'NH
~ OR ~ SR


An object of a principal aspect of the present invention is to
provide a new process for producing prazosine, differing from previously
known processes Ln the resEeot that the formation of the quin201ine ring
occurs within the ~lecule to form the final oo~po,und ana not, as in kncwn
processes, in a reaction between two different m~lecules.

The proce~s accor,ding ~o a broad aspect of this Lnvention for ErO-

ducing prazosine9 6,7-dimetho~y-4-amino-2- r4- (2-furoyl)-1-piFerazinyl~
zollne, ~ rises: re~ct ~ 3,4 ~ imet ~ -6-~4-~2-furoyl)-1-piperazinyl-
thiocarbanido~benzonitrile, having the formLla

. .
CH30~NH ~ N ~ OC

CH30 CN II


with methyl iodide~ to fonm methyl N-(3~4-dimethlxy-6-cyanophenyl)-~4-(2-
furoyl)-l-pip~razinyl]-thioformamidate, having the ~ornNla
-- 3 --

~0Y~Z~l~
~,
CH3~N=~--.'\1 N - O

CH3 o CN
III,

and cyclizing such compound (III) by heating it, together with ammonia, in
a polar solvent in the presence of alkali metal amide.
By one variant of this process, the reaction of the compound hav-
ing formula (II) with methyl iodide is performed in formamide, in N,N-


dimethyl formamide, in bis-methoxyethyl ether (diglyme), or in a mixture
of such solvents, at 50-100C.
By another variant, the cyclization is performed in formamide or
in N,N-dimethyl formamide at 100-150C, using 1-3 equivalents of an alkali
metal amide.
By yet another variant, the reaction of the compound having for-
mula II with methyl iodide and the cyclization of the compound having
formula III is performed continuously in one and the same solvent without
separating the intermediate products.
The compound 3,4-dimethoxy-6-E4-(2-furoyl)-1-piperazinyl-thio-
carbamido]benzonitrile (II) used as the initial substance is a new com-


pound; Processes for the production of this compound having formula (II)20
are disclosed and claimed in copending Canadian application Serial No.
293,066 filed Dec. 14, 1977. However, in summary, such compound can be
prepared starting from 3,4-di-methoxy-6-aminobenzonitrile and 1-(2-furoyl)
piperazine, using the processes illustrated by the reaction formulas
below:




-- 4 --

~z~

Cll 30~ CS C 12 3 ~ NCS
CH30 CN C~13~) CN
IV V


.~ V I I V I

r~ ~
CH30~NH- I - N N - OC

CH30 CN
II

HN~I--OC ~ ~ Cl-~-N~I OC

VI VII

~ ccording to the first alternative, 3,4~dimethQxy-6-amino-benzoni-
trile tIV) is first allowed to react with thiophosgene to fonm 3,4-dimethQxy-
6-isothiocyanatobenzonitrile ~l), an~ then further with 1-(2-furoyl) pipera-

zine ~I) to form 3,4-dimethoxy-6-~4--(2-furoyl)-1-piperazinylthiocarbamido]
benzonitrile ~II). Alternatively, oQ~pound II can be produced by allowing
1-(2-furoyl~pip2razine ~VI) to react first with thiophosgene to form acid
chloride VII, and thereafter with 3,4-d~methcxy-6-amunobenzonitrile (IV~.
As disclosed above the prccess according to one aspect of the in-
vention can also be carried out so that the production o~ prazosine starting
fm m 3,4-dimetho~y-6-~4-~2-furoyl)-1-piperazinylthiocarb~mido]benzanitrile
(II), (even starting from 3,4-di~methcxy-6-isothiocyanato~enzonitrile ~V)),
can be perfoLmed continuously in one and the same reaction vessel and in cne


' - ~ a,

~Zl~IL7

in one and~the sc~me solvent, e.g. Eormamide, without separatiny the inter-
mediate products.
me followin~ examples will illustrate various a~pects of the
invention.




- 4 b -

1[39Z~7

r`xamp:Le 1
a) 3,4-dimethoxy-6-isothiocyanatoben7Onitri:Le (V)
27,0 ~ (0.15 mo:Le) o~ 3,4-~i~nethoxy-6-~tlinol-x~n%onitr:ile (IV) is
dissolved in 150 ml of 1,2-dichloroethane~ anrl added cJradually
at 0-5C to a rnixture which contains 23.0 g (0.2 mvle) of
thiophosc3ene, 100 ml of 1,2-dichloroethane, 20.0 cJ (0.2 mole)
of calcium carbonate, and 200 ml oE water. After this addition,
the mixture is stirred for 1 hour at 0-5C, thereafter for 16
hours a-t 20C, and finally Eor 1 hour at 35C. The reaction
mixture is ~ tered and the dichloroethane layer separa-ted,
washed with dilute hydrochloric acid and wa-ter, and dried with
MqSO~. The solvent is removed in vacuum, and the crystalline
residue (m.p. 126-127C) is used as such for the nex-t s-tage. The
yield is 31.0 g (94~ of the -theoretical) of 3,9-dimethoxy-6-
isothiocyanatobenzonitrile.

C10I~8N22S calc. C = 54.53 Obs. C = 53.43
El = 3.66 l-l = 3.78
N = 12.72 N = 12.18
S = 14.56 S = 13.79

b) 3,4-dimethoxy-6-i4-(2-furoyl)-1-piperazinylt}liocarbamidol-
benzonitrile (II)
11.2 g (0.051 mole) of 3,4-dimethoxy-6-isothiocyanatobenzonitrile
(V) is dissolved in 65 Ml of ethyl acetate and added ~radually,
while stirring , at 0C to a solution which contains 9.2 g
(0.051 mole) of 1-(2-furoyl)-piperazine in 65 ml of ethyl
ace-tate. The solution is allowed to stand overnight at -25C,
whereby the product crys-tallizes. It is filtered and the crys-tals
are washed wi-th cold ethyl acetate and dried. The yield is 16~3 g
(80~ of the theoretical) of 3,4-dimethoxy-6-14-(2-furoyl)-
l-piperazinylthiocarbamidolbenzonitrile. M.p. 178-180C.

19 20N4O4S Calc. C = 56.99 Obs. C = 57.41
H = 5.03 H = 5.39
N = 13.99 N = 14.14
S = 8.01 S = 7.68
. ~

092~

_ample 2
3~4-dimethoxy-6-l4-(2-Euroyl)-]-piperaz:inylth:iocar~amido~benzo-
nitrile (IL)
5.0 C3 (0.02~ moJe) of 1-(2-Euroyl)piE)erLlzirle (VI) and 2.33 ~3
(0.028 mole) of triethylamine are dissolvecl in 60 ml of
dichlorometlla1le. 'rhis solution is addecl, while stirrinc3 , at
approx. 0C to a mixture which contains 3.~ g (0.0336 Mole)
of thiophoscJene in 50 mJ of dichloromethane. After this addition,
the mixture is stirr~d for Z hours at 0C and for 3 hours at
room -temperature. The triethylamine hydroch]oride is filtered
off, and the solution is completely evaporated in a vacuum. The
residue, 9-(2-furoyl)piperazinyl-thiocarbonyl chloride (VII),
is redissolved in 50 ml of dichloromet}lane and added, while
aqitating, at 0C to a solution which contains 4.98 g (0.028 mole)
of 3,4-dime-thoxy-6-aminobenzonitrile (IV) and 2.83 ~ (0.028
mole) of triethylamine in 60 ml of dichloromethane. The mixture
is~agitatecl for 2 hours a-t 0C and thereaE-ter for 2 3 hours
at room tempera-ture. The triethylamine hydrochloride is filtered
off, and the solution is washed with water, dried with M~SO4,
and completely evaporated in a vacuum. ~thyl acetate is added,
the mix-ture is cooled -to -25C and filtered. I'he yield is 6.2 g
(55% of the theore-tical) of 3,4-dimethoxy-6-[4-(2-furoyl)-1-
piperazinylthiocarbamidoJbenzonitrile. M.p. 175-178C.

Exam~le 3
a) Methyl N-(3,4-dimethoxy-6-cyanophenyl)-14-(2-furoyl)-1-
piperazinyl~thioformamidate hydrolodide (III-HI)
20;0 C3 (0.05 mole) of 3,4-dimethoxy-6-l4-(2-furoyl)~l-
piperazinylthiocarbamido~benzonitrile is dissolved in 200 ml of
bis-methoxyethyl ether (diglyme), and 14.2 ~3 (0.1 mole) of
methyl iodide is added. The mixture is refluxed for
9 hours at 60C. The solution is cooled to room
temperature and filtered. The crys-talline reac-tion product is
washed with ether al-d dried. The yield is 24.6 c3 (90~ of the
theoretical) of methyl N~(3,4-dimethoxy-6-cyanopllenyl)-l4-(2-
furoyl)-l-piperazinyll-thioformami-:late hyclroioclide. M.p. 163C.

~09Z~i7
C20H23IN404S Calc. C - 44.29 Obs C = 44.25
H = '~.27 ~ ~ 4.26
I = 23.39 I = 22.93
N = 10,33 N = 9.61
S = 5.91 S = 5.58
b) Methyl N~(3l4~dimethoxy-6-cyanophenyl~r4~(2~furoyl)-l~piperazinyl]thio-
formamidate (III)
62.0 g (0.114 mole) of methyl N-(3,4~dimethoxy~6~cyanophenyl)~[4-(2-
furoyl)~l~piperazinyl]thioformamidate hydroiodide i9 dissolved at 0~5C
in 350 ml of methanol, and 186 ml of a 25 % ammonia solution is added,
while stirring. The mixture is agitated for 2 hours at 0C, filtered, and
washed with ether. The yield is 42,7 g (90 of the theoretical) of
methyl N-(3,4~dimethoxy~6~cyanophenyl)~r4~(2-furoyl)~l~piperazinyl]~
thioformamidate. M.p. 105~107C. ,

20 22N44S Calc. C = 57.95 Obs. C = 58.01
H = 5.36 H = 5.54
N = 13.52 N = 13.73
S = 7.73 S = 7.53
c) 6,7-dimethoxy-4~amino~2 [4~(2~furoyl)-l~piperazinyl]~quinazoline (I)
7.0 g (0.017 mole) of methyl N~(3,4~dimethoxy-6-dyanophenyl)~~4-(2-furoyl)-
l~pipera~inyl]thioformamidate is dissolved in 100 ml of formamide, and
2.0 g (0.051 mole) of sodium amide is addedO The solution is saturated
wlth NH3 gas at 0C. The temperature of the solution is rised slowly to
120 C, and it is heated for 24 more hours at this temperature, in th~ stream
of NH3 gas. The cooled reaction mixture is poured into 100 ml of ice
water and extracted 6~7 times with 50 ml of chloroform. The chloroform
extract is washed 4 times with 50 ml of water, dried, and completely
evaporated in a vacuum. The product is crystallized from an ethanol~
water mixture (50:15). The product is 6,7-dimethoxy-4-amino~2-[4~(2-

2~L~iL7
furoyl)-l-piperazinyl.]-qu:Lnazollne, M.p. 262-264C. The IR and NMR
spectra of the product are identical ~7ith the spectra of the compound
produced by processes prevlously described in literature.




- 7 a -

Z~l~




19 21 5 4 Ca]c. C = 59.52 Obs. C = 59.28
Il = 5.52 ll = 5.88
N = 18.27 N = 17.99

Example 4
6,7-dimethoxy-4-amino-2-14-(2-furoyl)-1-piperazlnyllquinazoline
(Ij
9.7 g (0.044 mole) of 3,4-dimethoxy-6-iso-thiocyanatobenzonitrile
(V) is suspellded in :100 ml oE formamide, and to this suspension
is added CJI. adually, while stirring, at room temperature
7.9 y (0.044 mole) of 1-(2-furoyl)piperazine (VI) dissolved in
65 ml of formamide. After this addition, the stirring is
continued at room temperature until all of -the 3,4-dimethoxy-
6-isothiocyanatobenzonitrile is dissolved (3-4 hours). There-
after 12.5 g (0.088 mole) of methyl iodide is added to the
mixture and the mixture is heated for 9 hours at 60C. Excess
methyl iodide is removed by evaporating and the solution is
satura~ted with Nl13 gas at 0C, and 6.9 g (0.176 mole) of
sodium amide is added to the solu-tion. The ternperature is
rised to 120-l90C, and the so]ution ls heated for 24 hours
at this-te~lr~erature, in ~le stream of NE13 cJas. The cooled reaction
mixture is poured into ice water (approx. 150 ml) and extracted
using chloroform (8 x 50 ml). The chloroform extract is washed
with water, treated wi-th activa-ted carbon, dried, and completely
evaporated in a vacuum. The resiclue is crystallized from an
ethanol-water mixture (50:15). The product is
6,7-dimethoxy-4-amino-2-14-(2-furoyl)-1-piperazinyl]quinazoline.
M.p. 263-265C.




-- 8 --

Dessin représentatif

Désolé, le dessin représentatatif concernant le document de brevet no 1092117 est introuvable.

États administratifs

Pour une meilleure compréhension de l'état de la demande ou brevet qui figure sur cette page, la rubrique Mise en garde , et les descriptions de Brevet , États administratifs , Taxes périodiques et Historique des paiements devraient être consultées.

États administratifs

Titre Date
Date de délivrance prévu 1980-12-23
(22) Dépôt 1977-12-14
(45) Délivré 1980-12-23
Expiré 1997-12-23

Historique d'abandonnement

Il n'y a pas d'historique d'abandonnement

Historique des paiements

Type de taxes Anniversaire Échéance Montant payé Date payée
Le dépôt d'une demande de brevet 0,00 $ 1977-12-14
Titulaires au dossier

Les titulaires actuels et antérieures au dossier sont affichés en ordre alphabétique.

Titulaires actuels au dossier
ORION-YHTYMA OY
Titulaires antérieures au dossier
S.O.
Les propriétaires antérieurs qui ne figurent pas dans la liste des « Propriétaires au dossier » apparaîtront dans d'autres documents au dossier.
Documents

Pour visionner les fichiers sélectionnés, entrer le code reCAPTCHA :



Pour visualiser une image, cliquer sur un lien dans la colonne description du document. Pour télécharger l'image (les images), cliquer l'une ou plusieurs cases à cocher dans la première colonne et ensuite cliquer sur le bouton "Télécharger sélection en format PDF (archive Zip)" ou le bouton "Télécharger sélection (en un fichier PDF fusionné)".

Liste des documents de brevet publiés et non publiés sur la BDBC .

Si vous avez des difficultés à accéder au contenu, veuillez communiquer avec le Centre de services à la clientèle au 1-866-997-1936, ou envoyer un courriel au Centre de service à la clientèle de l'OPIC.


Description du
Document 
Date
(yyyy-mm-dd) 
Nombre de pages   Taille de l'image (Ko) 
Dessins 1994-04-20 1 13
Revendications 1994-04-20 2 45
Abrégé 1994-04-20 1 16
Page couverture 1994-04-20 1 17
Description 1994-04-20 10 295